When it comes to your body's health, nothing reacts faster or is more important than your immune system. From infections to chronic illness, your immune system responds. We believe longitudinal immune system metrics will be the next frontier in medical surveillance and treatment. But until now, nobody was listening.
Your immune system is a continuous surveillance network, constantly sensing what's happening across your body and coordinating responses through cytokines, small signaling proteins that drive inflammation and shape disease progression. When something starts to go wrong, cytokines shift first: hours before an autoimmune flare, weeks before a cardiac event, and long before many cancers become clinically visible. These signals have always been there. We just couldn't read it.
The limitation with legacy system testing is architectural, not technical.
Cytokines are time sensitive and can degrade quickly once blood leaves the body, making centralized lab workflows poorly suited for immune monitoring. And even when measured accurately, a single cytokine value rarely has a clear meaning on its own. Context matters, the surrounding marker pattern, and most importantly, the trend over time.
Biomarkr was built to generate longitudinal immune system data to solve this problem.
Our silicon photonic biosensor delivers lab grade cytokine measurement from a fingerstick sample at the point of need in under ten minutes. When testing becomes easy, frequency changes. Weekly or daily measurement turns isolated readings into a personal baseline and a measurable trajectory. Drift becomes visible. Deviations can be detected earlier, often before symptoms appear.
We are not building a faster diagnostic. We are building the measurement infrastructure for predictive, personalized, immune-driven medicine.
